Revolutionizing treatment for patients in need

Scroll To Discover
Young woman smiling. Young woman smiling. Young woman smiling.

About

We’re committed to delivering boundless therapeutic ingenuity

Tarsus Pharmaceuticals, Inc. is a biopharmaceutical company that embodies the values of commitment, empowerment, and teamwork. We aim to bring novel therapeutics to patients across a range of diseases with limited treatment options.

Product

Novel therapies, beginning with the eye

For the millions of patients living with Demodex blepharitis, an FDA-approved treatment is here.

News & Media

Here is the latest from Tarsus

09/06/2023 Tarsus to Ring Nasdaq Stock Market Closing Bell in Celebration of the Launch of XDEMVY™, the First and Only FDA Approved Treatment for Demodex Blepharitis
08/30/2023 Tarsus to Present at Upcoming Investor Conferences
08/24/2023 Now Available – XDEMVY™ (lotilaner ophthalmic solution) 0.25%, the First and Only FDA Approved Treatment for Demodex Blepharitis
XDEMVY logo

NOW AVAILABLE

GO TO XDEMVY.COM

Contact Tarsus

Please reach out to us using the form below.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.